---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-22-000302"
form_type: "8-K"
ticker: "CHE"
cik: "0000019584"
company_name: "CHEMED CORP"
filed_at: "2022-07-27T23:59:59+00:00"
generated_at: "2026-06-24T08:20:46.987624+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Chemed Q2 adj EPS $4.84, raises FY22 guidance low-end to $19.30; Roto-Rooter revenue +6%

## Summary
- Revenue $531M, down 0.2% YoY; GAAP diluted EPS $4.40 (+25.4%); adjusted diluted EPS $4.84 (+5.2%).
- VITAS revenue $298M (-4.5%); ADC 17,315 (-3.8%); admissions -12.5%; adj EBITDA margin 16.7% (-78bps).
- Roto-Rooter revenue $233M (+6.0%); adj EBITDA $69.0M (+7.4%); margin 29.6% (+39bps).
- FY2022 adjusted EPS guidance raised to $19.30-$19.50 from $19.10-$19.50; VITAS rev. decline 4.5-5.0%, Roto-Rooter growth 5.5-5.7%.
- Repurchased 100,000 shares for $49.9M at avg $498.61; entered new $550M credit agreement in June.

## SEC filing metadata
- accession: 0001562762-22-000302
- form_type: 8-K
- ticker: CHE
- cik: 0000019584
- company_name: CHEMED CORP
- filed_at: 2022-07-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/19584/000156276222000302/0001562762-22-000302-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/19584/000156276222000302/che-20220727x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-22-000302
- JSON: https://secwatch.observer/filing/0001562762-22-000302.json
- Plain text: https://secwatch.observer/filing/0001562762-22-000302.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.